We aim to improve Saccharomyces cerevisiae as an oral vaccine vector platform for use with poultry, focusing on the economically significant disease coccidiosis. We have developed a yeast-delivery platform in which antigens from Eimeria can be expressed in a stable, non-secreted form, with the yeast itself acting as transport system and adjuvant.